Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb 11;5(2):e002040.
doi: 10.1136/bmjgh-2019-002040. eCollection 2020.

The household economic burden of non-communicable diseases in 18 countries

Affiliations

The household economic burden of non-communicable diseases in 18 countries

Adrianna Murphy et al. BMJ Glob Health. .

Abstract

Background: Non-communicable diseases (NCDs) are the leading cause of death globally. In 2014, the United Nations committed to reducing premature mortality from NCDs, including by reducing the burden of healthcare costs. Since 2014, the Prospective Urban and Rural Epidemiology (PURE) Study has been collecting health expenditure data from households with NCDs in 18 countries.

Methods: Using data from the PURE Study, we estimated risk of catastrophic health spending and impoverishment among households with at least one person with NCDs (cardiovascular disease, diabetes, kidney disease, cancer and respiratory diseases; n=17 435), with hypertension only (a leading risk factor for NCDs; n=11 831) or with neither (n=22 654) by country income group: high-income countries (Canada and Sweden), upper middle income countries (UMICs: Brazil, Chile, Malaysia, Poland, South Africa and Turkey), lower middle income countries (LMICs: the Philippines, Colombia, India, Iran and the Occupied Palestinian Territory) and low-income countries (LICs: Bangladesh, Pakistan, Zimbabwe and Tanzania) and China.

Results: The prevalence of catastrophic spending and impoverishment is highest among households with NCDs in LMICs and China. After adjusting for covariates that might drive health expenditure, the absolute risk of catastrophic spending is higher in households with NCDs compared with no NCDs in LMICs (risk difference=1.71%; 95% CI 0.75 to 2.67), UMICs (0.82%; 95% CI 0.37 to 1.27) and China (7.52%; 95% CI 5.88 to 9.16). A similar pattern is observed in UMICs and China for impoverishment. A high proportion of those with NCDs in LICs, especially women (38.7% compared with 12.6% in men), reported not taking medication due to costs.

Conclusions: Our findings show that financial protection from healthcare costs for people with NCDs is inadequate, particularly in LMICs and China. While the burden of NCD care may appear greatest in LMICs and China, the burden in LICs may be masked by care foregone due to costs. The high proportion of women reporting foregone care due to cost may in part explain gender inequality in treatment of NCDs.

Keywords: cardiovascular disease; diabetes; health economics; health insurance; health systems.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Economic burden of healthcare costs, comparing NCD, HTN only and non-NCD/HTN households by country income group, PURE Study. HIC, high-income country; LIC, lower income country; LMIC, lower middle income country; NCD, non-communicable disease; PURE, Prospective Urban and Rural Epidemiology; UMIC, upper middle income country.

Similar articles

Cited by

References

    1. World Health Organization . Technical note: how who will report in 2017 to the United nations General assembly on the progress achieved in the implementation of commitments included in the 2011 un political Declaration and 2014 un outcome document on NCDS. Geneva: World Health Organization, 2017.
    1. Jaspers L, Colpani V, Chaker L, et al. . The global impact of non-communicable diseases on households and impoverishment: a systematic review. Eur J Epidemiol 2015;30:163–88. 10.1007/s10654-014-9983-3 - DOI - PubMed
    1. Khatib R, McKee M, Shannon H, et al. . Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the pure study data. The Lancet 2016;387:61–9. 10.1016/S0140-6736(15)00469-9 - DOI - PubMed
    1. Attaei MW, Khatib R, McKee M, et al. . Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the pure study data. The Lancet Public Health 2017;2:e411–9. 10.1016/S2468-2667(17)30141-X - DOI - PubMed
    1. Mendis S, et al. . The availability and affordability of selected essential medicines for chronicl diseases in six low- and middle-income countries. Bull World Health Organ 2007;85:279–88. 10.2471/BLT.06.033647 - DOI - PMC - PubMed

Publication types

LinkOut - more resources